Efgartigimod Alfa And Hyaluronidase Human Recombinant + Human Botulinum Neurotoxin Ab Immune Globulin Interaction
Moderateinteraction on record
Description
Concomitant use may lower systemic exposures and reduce effectiveness. Closely monitor for reduced effectiveness.
Mechanism
Competition for human neonatal Fc receptor (FcRn) binding
Source: NLP:efgartigimod alfa and hyaluronidase (human recombinant)